Skip to content Skip to footer
DHS Hungary
Get in touch
DHS Hungary
Get in touch
Close

Welcome VitaFlow Liberty

Innovation, TAVI, VitaFlowAugust 12, 2025420Views0Likes0Comments
We are thrilled to announce the launch of MicroPort CardioFlow VitaFlow LibertyT, a groundbreaking TAVI device in Hungary! After the first cases at Semmelweis University Heart and Vascular Centre, Gottsegen National Cardiovascular Center, and University of Debrecen, we are confident that this innovative technology represents a new era in transcatheter aortic valve implantation. We're excited to…

Read More

Successful Castor-Minos Workshop in Perugia

Castor, Innovation, Lombard, Minos, WorkshopJune 3, 2025369Views0Likes0Comments
We were honored to participate in the Castor-Minos Workshop held in Perugia, an event marked by clinical excellence and inspiring collaboration. A big thank you to Dr. Giacomo Isernia and his colleagues for their insightful contributions and hands-on demonstrations. We also extend our gratitude to Claudio Moscheni from Lombard Endovastec for his outstanding support, organization,…

Read More

DHS at NAÉS Congress

Congress, Innovation, NeurologyMay 29, 2025410Views0Likes0Comments
Earlier this month, we participated in the NAÉS Congress – the Forum of Neurointerventional and Cerebrovascular Specialists – a standout event for Hungary’s neurovascular community. We are especially proud of the DHS industry symposium, which drew significant attention and engagement from participants. It was inspiring to see so many professionals come together to exchange knowledge…

Read More

Engaging the next generation of vascular specialists

Bentley, Congress, Innovation, PenumbraMay 9, 2025384Views0Likes0Comments
We were honored to take part in the 1st Congress of the Young Vascular Specialists’ Section (FÉSZ), an exceptional event dedicated to the future of vascular medicine. As part of the program, we hosted two interactive workshops. The Penumbra Lightning session offered participants a close-up look at advanced technologies in thromboembolism treatment. The Bentley BeGraft…

Read More

Milestone Achievement with Bentley BeFlared

Bentley, First Case, InnovationApril 30, 2025509Views0Likes0Comments
Announcing the first-ever use of the Bentley BeFlared bridging covered stent in Pécs, marking a significant advancement in complex endovascular treatment. At University of Pécs, Dr. Gábor KASZA and Dr. Gábor FAZEKAS successfully performed a custom-made Treo by Terumo Aortic FEVAR implantation, combined simultaneously with the deployment of Bentley BeFlared stent. This case demonstrates the…

Read More

DHS Hungary is awarded as P4S Gold Winner 2024

Boston Scientific, InnovationMarch 17, 2025456Views0Likes0Comments
We are thrilled to announce that DHS Hungary has been honored with the P4S (Partners for Success) Award, proudly earning the Gold Winner 2024 title! This recognition highlights the relentless effort, commitment, and outstanding teamwork we've built with our fantastic partners across. Together we’ve made great progress in advancing cutting-edge solutions and enhancing patient care.…

Read More

A new Milestone in Endovascular Treatment

Bentley, First Case, InnovationMarch 13, 2025435Views0Likes0Comments
Proudly announcing the first-ever Bentley BeFlared intervention in Hungary! The BeFlared is one of the first two dedicated FEVAR bridging stents, featuring a unique design. With its stepped balloon and additional radiopaque marker, it enables precise positioning and accurate deployment – providing endovascular specialists with a more efficient solution for complex aortic aneurysm treatment. Great…

Read More

UniVas Aortic Symposium – A Journey of Knowledge and Innovation

Congress, Innovation, Lombard, MinosFebruary 25, 2025482Views0Likes0Comments
It was a privilege to attend the UniVas Aortic Symposium, organized by Microport Endovastec. The first segment of the training took place at Microport's headquarters in Shanghai, where we extend our heartfelt thanks to Vivien Yao, Claudio Moscheni, and Prof. Dr. Quingsheng Lu for their exceptional support and invaluable insights, which significantly enriched the experience.…

Read More

Advancing Stroke Prevention: The OPTION Trial

Boston Scientific, Innovation, LAAC, WatchmanJanuary 8, 2025391Views0Likes0Comments
Exciting news in the realm of stroke prevention! The OPTION Trial highlights the safety and effectiveness of left atrial appendage closure (LAAC) using the Watchman FLX™ device as an alternative to oral anticoagulants in patients undergoing AFib ablation. This study reinforces the potential of LAAC to reduce stroke risk while addressing bleeding concerns, offering hope…

Read More